Eli Lilly's rating gets an upgrade to Aa3 by Moody's Ratings
The upgrade is based on Moody's expectation of robust earnings growth for Eli Lilly in the coming years. This growth is ...
LLY Beats Q4 Earnings & Sales, Gives 2025 EPS Guidance
This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, AstraZeneca AZN and AbbVie announced their fourth-qua ...
Is the promise of more affordable weight loss drugs too good to be true? Compounded semaglutide, explained.
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
News Medical on MSN10h
Vision loss risks in patients using popular GLP-1 medications raise concerns
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Zacks.com on MSN22h
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...
Hosted on MSN16h
Kelly Clarkson Lost 60 Lbs. by Walking More-Get Tips to Boost Your Calorie Burn
After Kelly Clarkson debuted her striking weight loss in 2023, many suspected her success was due to Ozempic. While the ...
Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Therapy dog brings joy to medical center patients, staff
Kismet, an English Springer Spaniel, and her owner Stacey Yeoman have been bringing joy to patients and staff at Novant Health Mint Hill Medical Center for the past two months as a therapy dog team.